Papadopoulos C - Search Results

1

Motor unit potential changes in myofibrillar myopathy.

Anagnostou E, Vasilakou I, Papadopoulos C, Zambelis T, Papadimas G. Anagnostou E, et al. Among authors: papadopoulos c. J Neurol Sci. 2019 May 15;400:110-112. doi: 10.1016/j.jns.2019.03.017. Epub 2019 Mar 20. J Neurol Sci. 2019. PMID: 30913523 No abstract available.

2

Body composition analysis in late-onset Pompe disease.

Papadimas GK, Terzis G, Methenitis S, Spengos K, Papadopoulos C, Vassilopoulou S, Kavouras S, Michelakakis H, Manta P. Papadimas GK, et al. Among authors: papadopoulos c. Mol Genet Metab. 2011 Jan;102(1):41-3. doi: 10.1016/j.ymgme.2010.09.002. Epub 2010 Sep 16. Mol Genet Metab. 2011. PMID: 20926325

3

Adult Pompe disease: clinical manifestations and outcome of the first Greek patients receiving enzyme replacement therapy.

Papadimas GK, Spengos K, Konstantinopoulou A, Vassilopoulou S, Vontzalidis A, Papadopoulos C, Michelakakis H, Manta P. Papadimas GK, et al. Among authors: papadopoulos c. Clin Neurol Neurosurg. 2011 May;113(4):303-7. doi: 10.1016/j.clineuro.2010.12.005. Epub 2011 Jan 7. Clin Neurol Neurosurg. 2011. PMID: 21216089

4

Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy.

Terzis G, Dimopoulos F, Papadimas GK, Papadopoulos C, Spengos K, Fatouros I, Kavouras SA, Manta P. Terzis G, et al. Among authors: papadopoulos c. Mol Genet Metab. 2011 Nov;104(3):279-83. doi: 10.1016/j.ymgme.2011.05.013. Epub 2011 May 19. Mol Genet Metab. 2011. PMID: 21640624

5

Late onset glycogen storage disease type II: pitfalls in the diagnosis.

Papadimas GK, Spengos K, Papadopoulos C, Manta P. Papadimas GK, et al. Among authors: papadopoulos c. Eur Neurol. 2012;67(2):65-8. doi: 10.1159/000334398. Epub 2011 Dec 15. Eur Neurol. 2012. PMID: 22179097

6

Effects of exercise training during infusion on late-onset Pompe disease patients receiving enzyme replacement therapy.

Terzis G, Krase A, Papadimas G, Papadopoulos C, Kavouras SA, Manta P. Terzis G, et al. Among authors: papadopoulos c. Mol Genet Metab. 2012 Dec;107(4):669-73. doi: 10.1016/j.ymgme.2012.10.020. Epub 2012 Oct 24. Mol Genet Metab. 2012. PMID: 23146291

7

OX40-OX40L expression in idiopathic inflammatory myopathies.

Papadopoulos C, Terzis G, Papadimas GK, Manta P. Papadopoulos C, et al. Anal Quant Cytopathol Histpathol. 2013 Feb;35(1):17-26. Anal Quant Cytopathol Histpathol. 2013. PMID: 23469620

8

Bone density in patients with late onset Pompe disease.

Papadimas G, Terzis G, Papadopoulos C, Areovimata A, Spengos K, Kavouras S, Manta P. Papadimas G, et al. Among authors: papadopoulos c. Int J Endocrinol Metab. 2012 Fall;10(4):599-603. doi: 10.5812/ijem.4967. Epub 2012 Sep 30. Int J Endocrinol Metab. 2012. PMID: 23843830 Free PMC article.

9

Phenotypic variability and molecular genetics in proximal myotonic myopathy.

Papadimas GK, Kekou K, Papadopoulos C, Kararizou E, Kanavakis E, Manta P. Papadimas GK, et al. Among authors: papadopoulos c. Muscle Nerve. 2015 May;51(5):686-91. doi: 10.1002/mus.24440. Epub 2015 Mar 31. Muscle Nerve. 2015. PMID: 25186227

10

Caveolinopathies in Greece.

Papadopoulos C, Papadimas GK, Kekou K, Spengos K, Svigou M, Kitsiou-Tzeli S, Manta P. Papadopoulos C, et al. Neurologist. 2015 Jul;20(1):8-12. doi: 10.1097/NRL.0000000000000036. Neurologist. 2015. PMID: 26185955

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

583 results

Search Page